Sociedad Argentina de Hematología

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ISSN 2250-8309

 

 

Formulario de cesión
de Derechos de Autor

Se solicita enviar el siguiente formulario, debidamente firmado por todos los autores del trabajo presentado:

 

  • Por Fax: 11 4855 2452
  • Personalmente en la SAH
  • o En archivo PDF por mail

 

Formulario de Cesión de Derechos de Autor
 

 

Revista Argentina de Hematología

Abstract

Volumen:    21    # Number : 2

Publication Date :    MAYO - AGOSTO    Year:    2017

   ARTÍCULO ORIGINAL

Comparison of heparin therapeutic range obtained with different protocols using ex vivo or in vitro heparin spiked normal plasma samples

Authors: Rosa CM, Burdet J, Rojas YN, Zirpoli MM

Abstract: For the monitoring of unfractionated heparin therapy (UFH) there are numerous pre-analytical, analytical and biological variables associated with the use of activated partial thromboplastin time (APTT), so the traditional range of 1.5-2.5 times the baseline value can lead to inadequate heparinization, resulting in thrombosis. Guidelines recommend to obtain the heparin therapeutic range (HTR) with ex vivo samples from patients under continuous heparin infusion therapy, measuring heparinemia by anti-Xa assay, since when in vitro UFH spiked plasmas are used, an overestimation of the therapeutic range is noted. The objective of this study was to compare the results of HTR obtained using ex vivo samples and in vitro heparin spiked normal plasma samples. HTR for ex vivo samples resulted in 56-87 sec by anti-Xa assay. For in vitro spiked samples HTR was 55-127 sec. Using an alternative in vitro protocol correlating the APTT with UFH concentration between 0.2 and 0.4 IU/ ml, the HTR was 55-85 sec. The results also showed that there is an overestimation of HTR with the in vitro protocol especially at high concentrations, whereas the lower value of the range does not have significant differences when we compared both methods. Laboratories that do not have anti-Xa assay could obtain an estimate of the lower value of the HTR with an alternative protocol in vitro.

Key words: Heparina no fraccionada, Tiempo de tromboplastina parcial activado, Anti-Xa, Rango terapéutico de heparina.

Pages :

  Resumen             pdf  

SOCIEDAD ARGENTINA DE HEMATOLOGÍA
Julián Alvarez 146 - Ciudad Autónoma de Bs As - Argentina
(54-11) 4855-2452 / 2485

http://www.sah.org.ar/revista/